1-Methyl-4-phenylpyridinium affects fast axonal transport by activation of caspase and protein kinase C
暂无分享,去创建一个
R. Llinás | M. Sugimori | Y. Serulle | G. Pigino | S. Brady | J. E. Moreira | G. Morfini | K. Opalach | Scott T. Brady | Jorge Eduardo Moreira | Mutsuyuki Sugimori | Rodolfo R. Llinás | Scott T. Brady | R. R. Llinás | S. T. Brady
[1] R. Llinás,et al. 1-Methyl-4-phenylpyridinium induces synaptic dysfunction through a pathway involving caspase and PKCδ enzymatic activities , 2007, Proceedings of the National Academy of Sciences.
[2] K. Talbot,et al. The molecular genetics of non-ALS motor neuron diseases. , 2006, Biochimica et biophysica acta.
[3] Thomas H. Gillingwater,et al. Synaptic Vulnerability in Neurodegenerative Disease , 2006, Journal of neuropathology and experimental neurology.
[4] G. Pigino,et al. JNK mediates pathogenic effects of polyglutamine-expanded androgen receptor on fast axonal transport , 2006, Nature Neuroscience.
[5] D. Gonzalez-Dunia,et al. Borna Disease Virus Blocks Potentiation of Presynaptic Activity through Inhibition of Protein Kinase C Signaling , 2006, PLoS pathogens.
[6] M. Fichera,et al. A missense mutation in the coiled-coil domain of the KIF5A gene and late-onset hereditary spastic paraplegia. , 2006, Archives of neurology.
[7] M. Coleman. Axon degeneration mechanisms: commonality amid diversity , 2005, Nature Reviews Neuroscience.
[8] J. Joseph,et al. Death-associated Protein Kinase as a Sensor of Mitochondrial Membrane Potential , 2005, Journal of Biological Chemistry.
[9] G. Pigino,et al. Polyglutamine expansion diseases: failing to deliver. , 2005, Trends in molecular medicine.
[10] Bin Zhang,et al. Axonal transport defects: a common theme in neurodegenerative diseases , 2005, Acta Neuropathologica.
[11] R. Llinás,et al. Vesicular reuptake inhibition by a synaptotagmin I C2B domain antibody at the squid giant synapse. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[12] M. Esiri,et al. The extent of axonal loss in the long tracts in hereditary spastic paraplegia , 2004, Neuropathology and applied neurobiology.
[13] S. Lipton,et al. Molecular pathways to neurodegeneration , 2004, Nature Medicine.
[14] G. Pigino,et al. A novel CDK5‐dependent pathway for regulating GSK3 activity and kinesin‐driven motility in neurons , 2004, The EMBO journal.
[15] H. Pant,et al. Topographic regulation of phosphorylation in giant neurons of the squid, Loligo pealei: role of phosphatases. , 2004, Journal of neurobiology.
[16] Scott T. Brady,et al. Neuropathogenic Forms of Huntingtin and Androgen Receptor Inhibit Fast Axonal Transport , 2003, Neuron.
[17] W. Dauer,et al. Parkinson's Disease Mechanisms and Models , 2003, Neuron.
[18] M. Kitazawa,et al. Caspase‐3 dependent proteolytic activation of protein kinase Cδ mediates and regulates 1‐methyl‐4‐phenylpyridinium (MPP+)‐induced apoptotic cell death in dopaminergic cells: relevance to oxidative stress in dopaminergic degeneration , 2003, The European journal of neuroscience.
[19] Mark P Mattson,et al. Alzheimer's Presenilin 1 Mutations Impair Kinesin-Based Axonal Transport , 2003, The Journal of Neuroscience.
[20] Yasushi Hiraoka,et al. Mutations in Dynein Link Motor Neuron Degeneration to Defects in Retrograde Transport , 2003, Science.
[21] Zoran Brkanac,et al. Missense mutations in the regulatory domain of PKC gamma: a new mechanism for dominant nonepisodic cerebellar ataxia. , 2003, American journal of human genetics.
[22] Shin J. Oh,et al. Mutant dynactin in motor neuron disease , 2003, Nature Genetics.
[23] H. Matsuzaki,et al. Protein Kinase Cδ (PKCδ): Activation Mechanisms and Functions , 2002 .
[24] M. Pericak-Vance,et al. A kinesin heavy chain (KIF5A) mutation in hereditary spastic paraplegia (SPG10). , 2002, American journal of human genetics.
[25] S. Speciale,et al. MPTP: insights into parkinsonian neurodegeneration. , 2002, Neurotoxicology and teratology.
[26] Nancy Ratner,et al. Glycogen synthase kinase 3 phosphorylates kinesin light chains and negatively regulates kinesin‐based motility , 2002, The EMBO journal.
[27] M. Beal,et al. Caspase-9 Activation Results in Downstream Caspase-8 Activation and Bid Cleavage in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Parkinson's Disease , 2001, The Journal of Neuroscience.
[28] S. Brady,et al. Regulation of Kinesin: Implications for Neuronal Development , 2001, Developmental Neuroscience.
[29] R. Jope,et al. Caspase-3 activation induced by inhibition of mitochondrial complex I is facilitated by glycogen synthase kinase-3β and attenuated by lithium , 2001, Brain Research.
[30] J. Andersen,et al. The hunt for a cure for Parkinson's disease. , 2001, Science of aging knowledge environment : SAGE KE.
[31] E. Hirsch,et al. Caspase‐3 activation in 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐treated mice , 2001, Movement disorders : official journal of the Movement Disorder Society.
[32] M. Hengartner. The biochemistry of apoptosis , 2000, Nature.
[33] R. Scott,et al. MPTP Activates c‐Jun NH2‐Terminal Kinase (JNK) and Its Upstream Regulatory Kinase MKK4 in Nigrostriatal Neurons In Vivo , 2000, Journal of neurochemistry.
[34] L. D. De Girolamo,et al. Effects of 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine on Differentiating Mouse N2a Neuroblastoma Cells , 2000, Journal of neurochemistry.
[35] E. Hirsch,et al. Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[36] J Q Trojanowski,et al. Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[37] N. Thornberry,et al. Inhibition of Human Caspases by Peptide-based and Macromolecular Inhibitors* , 1998, The Journal of Biological Chemistry.
[38] J. Mankovich,et al. Substrate Specificities of Caspase Family Proteases* , 1997, The Journal of Biological Chemistry.
[39] S. Brady,et al. Immunochemical analysis of kinesin light chain function. , 1997, Molecular biology of the cell.
[40] M. Gschwendt,et al. Inhibition of protein kinase C μ by various inhibitors. Inhibition from protein kinase c isoenzymes , 1996 .
[41] S. Jaken. Protein kinase C isozymes and substrates. , 1996, Current opinion in cell biology.
[42] R. Weichselbaum,et al. Proteolytic activation of protein kinase C delta by an ICE‐like protease in apoptotic cells. , 1995, The EMBO journal.
[43] D. Pappin,et al. The myristoylated alanine-rich C-kinase substrate (MARCKS) is sequentially phosphorylated by conventional, novel and atypical isotypes of protein kinase C. , 1995, European journal of biochemistry.
[44] F. Marks,et al. Protein Kinase Cσ-specific Phosphorylation of the Elongation Factor eEF-1α and an eEF-1α Peptide at Threonine 431 (*) , 1995, The Journal of Biological Chemistry.
[45] S. Hirai,et al. Specificity of the high affinity interaction of protein kinase C with a physiological substrate, myristoylated alanine-rich protein kinase C substrate. , 1994, The Journal of biological chemistry.
[46] A. Marini,et al. 1-Methyl-4-phenylpyridinum kills differentiated PC12 cells with a concomitant change in protein phosphorylation , 1994, Brain Research.
[47] G. Bloom,et al. GTP gamma S inhibits organelle transport along axonal microtubules , 1993, The Journal of cell biology.
[48] J. Reinhard,et al. Subcellular Compartmentation of 2′Methyl MPP+ Can Explain Differences in Toxicity to Adrenal Chromaffin Cells , 1992, Annals of the New York Academy of Sciences.
[49] M. Herkenham,et al. Selective retention of MPP+ within the monoaminergic systems of the primate brain following MPTP administration: An in vivo autoradiographic study , 1991, Neuroscience.
[50] A. Nairn,et al. Protein kinase C substrate and inhibitor characteristics of peptides derived from the myristoylated alanine-rich C kinase substrate (MARCKS) protein phosphorylation site domain. , 1991, The Journal of biological chemistry.
[51] G. Bloom,et al. A monoclonal antibody against kinesin inhibits both anterograde and retrograde fast axonal transport in squid axoplasm. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[52] Sami I. Horih. Basic Neurochemistry , 1989, Neurology.
[53] W. J. Brooks,et al. Astrocytes as a primary locus for the conversion MPTP into MPP+ , 1989, Journal of Neural Transmission.
[54] J. Griffin,et al. Axonal transport in neurological disease , 1988, Annals of neurology.
[55] R. Lasek,et al. Attachment of transported vesicles to microtubules in axoplasm is facilitated by AMP-PNP , 1985, Nature.
[56] W. Nicklas,et al. Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. , 1985, Life sciences.
[57] D. Jacobowitz,et al. A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[58] K. Jellinger,et al. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. , 1973, Journal of the neurological sciences.
[59] P. Blumberg,et al. Regulation of cell apoptosis by protein kinase c δ , 2004, Apoptosis.
[60] D. Grimes,et al. Caudate nucleus pathology in Parkinson's disease: ultrastructural and biochemical findings in biopsy material , 2004, Acta Neuropathologica.
[61] E. Kosno-Kruszewska,et al. Degenerative axonal changes in the hippocampus and amygdala in Parkinson's disease. , 2003, Folia neuropathologica.
[62] R. Ehsanian,et al. Acute ultrastructural effects of MPTP on the nigrostriatal pathway of the C57BL/6 adult mouse: Evidence of compensatory plasticity in nigrostriatal neurons , 2000, Journal of neuroscience research.
[63] M. Saraste,et al. FEBS Lett , 2000 .
[64] S H Kaufmann,et al. Mammalian caspases: structure, activation, substrates, and functions during apoptosis. , 1999, Annual review of biochemistry.
[65] S J Kish,et al. Biochemical pathophysiology of Parkinson's disease. , 1987, Advances in neurology.
[66] R. Lasek,et al. Video microscopy of fast axonal transport in extruded axoplasm: a new model for study of molecular mechanisms. , 1985, Cell motility.